Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Survey on ICU organization and ICU admission after haematopoietic cell transplantation with special emphasis on infectious causes

Closed Survey/Study

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Joanna Drozd-Sokolowska

Infections following CAR-T therapy. A retrospective collaborative study between the Infectious Diseases Working Party (IDWP), the Cellular Therapy and Immunobiology Working Party (CTIWP), the Transplant Complications Working Party (TCWP) of the EBMT, the European Hematology Association (EHA), and the Medical College of Wisconsin.

Lymphome non hodgkinien (LNH)

Leucémie Aiguë Lymphoblastique (LAL)

GoCART Coalition

Infectious Diseases Working Party (IDWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Autoimmune and autoinflammatory complications after CAR-T cell therapy - a joint study on behalf of the EBMT - ADWP, CTIWP and TCWP

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Myélome multiple (MM) ou autre dyscrasies plasmocytaires (PCD)

Lymphome non hodgkinien (LNH)

GoCART Coalition

Autoimmune Diseases Working Party (ADWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Multicentric evaluation of CAR-T cell induced pseudoprogression prevalence (PrevCARTiPP)

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Friedrich Stoelzel

Thrombotic microangiopathy (TMA) after CAR-T cell therapy

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Guillaume Dachy

CAR-T cell outcomes in patients with comorbidities

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Evaluating the Impact of ABO Compatibility on Allogeneic Stem Cell Transplantation Outcomes

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Impact of body mass index on outcome of CART cell therapy

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Christian Schultze-Florey

Efficacy and outcomes of allogeneic hematopoietic stem cell boost in adult patients with poor graft function

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Tatiana Rudakova

Outcomes of Allogeneic Hematopoietic Cell Transplantation from ≤8/10-HLA matched unrelated donor

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

GVHD Prophylaxis with ATG or PTCy after alloSCT from unrelated donors

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

ATG in the MSD setting - a real-world evidence study based on the EBMT Registry

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Agnieszka Piekarska